These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37203213)

  • 1. A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine.
    Ambrosino P; Ragona F; Mosca I; Vannicola C; Canafoglia L; Solazzi R; Rivolta I; Freri E; Granata T; Messina G; Castellotti B; Gellera C; Soldovieri MV; DiFrancesco JC; Taglialatela M
    Epilepsia; 2023 Jul; 64(7):e148-e155. PubMed ID: 37203213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with
    Mosca I; Freri E; Ambrosino P; Belperio G; Granata T; Canafoglia L; Ragona F; Solazzi R; Filareto I; Castellotti B; Messina G; Gellera C; DiFrancesco JC; Soldovieri MV; Taglialatela M
    Front Cell Neurosci; 2024; 18():1367838. PubMed ID: 38644974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo variants in KCNA3 cause developmental and epileptic encephalopathy.
    Soldovieri MV; Ambrosino P; Mosca I; Servettini I; Pietrunti F; Belperio G; ; Syrbe S; Taglialatela M; Lemke JR
    Ann Neurol; 2024 Feb; 95(2):365-376. PubMed ID: 37964487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
    Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
    Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A KCNC1-related neurological disorder due to gain of Kv3.1 function.
    Clatot J; Ginn N; Costain G; Goldberg EM
    Ann Clin Transl Neurol; 2023 Jan; 10(1):111-117. PubMed ID: 36419348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations.
    Cameron JM; Maljevic S; Nair U; Aung YH; Cogné B; Bézieau S; Blair E; Isidor B; Zweier C; Reis A; Koenig MK; Maarup T; Sarco D; Afenjar A; Huq AHMM; Kukolich M; Billette de Villemeur T; Nava C; Héron B; Petrou S; Berkovic SF
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1263-1272. PubMed ID: 31353855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired excitability of fast-spiking neurons in a novel mouse model of
    Wengert ER; Cheng MA; Liebergall SR; Markwalter KH; Hong Y; Arias L; Marsh ED; Zhang X; Somarowthu A; Goldberg EM
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A KCNC1 mutation in epilepsy of infancy with focal migrating seizures produces functional channels that fail to be regulated by PKC phosphorylation.
    Zhang Y; Ali SR; Nabbout R; Barcia G; Kaczmarek LK
    J Neurophysiol; 2021 Aug; 126(2):532-539. PubMed ID: 34232791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
    Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
    Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter.
    Nissenkorn A; Kornilov P; Peretz A; Blumkin L; Heimer G; Ben-Zeev B; Attali B
    Epileptic Disord; 2021 Oct; 23(5):695-705. PubMed ID: 34519644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes.
    Li X; Zheng Y; Li S; Nair U; Sun C; Zhao C; Lu J; Zhang VW; Maljevic S; Petrou S; Lin J
    Ann Transl Med; 2021 Sep; 9(18):1397. PubMed ID: 34733949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutation.
    Kim H; Lee S; Choi M; Kim H; Hwang H; Choi J; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2018 May; 40(5):429-432. PubMed ID: 29428275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNC1-related disorders: new de novo variants expand the phenotypic spectrum.
    Park J; Koko M; Hedrich UBS; Hermann A; Cremer K; Haberlandt E; Grimmel M; Alhaddad B; Beck-Woedl S; Harrer M; Karall D; Kingelhoefer L; Tzschach A; Matthies LC; Strom TM; Ringelstein EB; Sturm M; Engels H; Wolff M; Lerche H; Haack TB
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1319-1326. PubMed ID: 31353862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.
    Feng H; Clatot J; Kaneko K; Flores-Mendez M; Wengert ER; Koutcher C; Hoddeson E; Lopez E; Lee D; Arias L; Liang Q; Zhang X; Somarowthu A; Covarrubias M; Gunthorpe MJ; Large CH; Akizu N; Goldberg EM
    Cell Rep Med; 2024 Feb; 5(2):101389. PubMed ID: 38266642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
    Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
    Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.
    Soldovieri MV; Freri E; Ambrosino P; Rivolta I; Mosca I; Binda A; Murano C; Ragona F; Canafoglia L; Vannicola C; Solazzi R; Granata T; Castellotti B; Messina G; Gellera C; Labalme A; Lesca G; DiFrancesco JC; Taglialatela M
    Pharmacol Res; 2020 Oct; 160():105200. PubMed ID: 32942014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain of function due to increased opening probability by two
    Nappi M; Barrese V; Carotenuto L; Lesca G; Labalme A; Ville D; Smol T; Rama M; Dieux-Coeslier A; Rivier-Ringenbach C; Soldovieri MV; Ambrosino P; Mosca I; Pusch M; Miceli F; Taglialatela M
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2116887119. PubMed ID: 35377796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open channel block of Kv3.1 currents by fluoxetine.
    Sung MJ; Ahn HS; Hahn SJ; Choi BH
    J Pharmacol Sci; 2008 Jan; 106(1):38-45. PubMed ID: 18187934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K
    Oliver KL; Franceschetti S; Milligan CJ; Muona M; Mandelstam SA; Canafoglia L; Boguszewska-Chachulska AM; Korczyn AD; Bisulli F; Di Bonaventura C; Ragona F; Michelucci R; Ben-Zeev B; Straussberg R; Panzica F; Massano J; Friedman D; Crespel A; Engelsen BA; Andermann F; Andermann E; Spodar K; Lasek-Bal A; Riguzzi P; Pasini E; Tinuper P; Licchetta L; Gardella E; Lindenau M; Wulf A; Møller RS; Benninger F; Afawi Z; Rubboli G; Reid CA; Maljevic S; Lerche H; Lehesjoki AE; Petrou S; Berkovic SF
    Ann Neurol; 2017 May; 81(5):677-689. PubMed ID: 28380698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP
    Ambrosino P; Freri E; Castellotti B; Soldovieri MV; Mosca I; Manocchio L; Gellera C; Canafoglia L; Franceschetti S; Salis B; Iraci N; Miceli F; Ragona F; Granata T; DiFrancesco JC; Taglialatela M
    Mol Neurobiol; 2018 Aug; 55(8):7009-7024. PubMed ID: 29383681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.